Insider trades

Evans John M.

Evans John M. made 0 buys and 9 sales on the open market in the last 12 months at Beam Therapeutics Inc. Each trade with the role, price and filing.

Insider trades

Where they report

CompanyRoleHolding afterLatest trade
Beam Therapeutics Inc.
NASDAQ:BEAM
Director, CEO1.05MOct 16, 2026

Open-market trades, newest first

CompanyDateTradeSharesPriceValueHolding afterFiled
Beam Therapeutics Inc.
NASDAQ:BEAM
Oct 16, 2026Sale25,000US$23.98US$600K1.05MOct 16, 2026
Beam Therapeutics Inc.
NASDAQ:BEAM
Oct 15, 2026Sale25,000US$23.57US$589K1.05MOct 16, 2026
Beam Therapeutics Inc.
NASDAQ:BEAM
Jun 30, 2026Sale23,100US$34.26US$791K1.05MJul 1, 2026
Beam Therapeutics Inc.
NASDAQ:BEAM
Jun 30, 2026Sale1,900US$34.84US$66,1961.05MJul 1, 2026
Beam Therapeutics Inc.
NASDAQ:BEAM
Jun 29, 2026Sale11,579US$35.91US$416K1.05MJul 1, 2026
Beam Therapeutics Inc.
NASDAQ:BEAM
Jun 29, 2026Sale13,421US$35.13US$471K1.06MJul 1, 2026
Beam Therapeutics Inc.
NASDAQ:BEAM
Apr 1, 2026Sale30,078US$24.58US$739K1.05MApr 6, 2026
Beam Therapeutics Inc.
NASDAQ:BEAM
Mar 31, 2026Sale25,000US$22.76US$569K987KApr 1, 2026
Beam Therapeutics Inc.
NASDAQ:BEAM
Mar 30, 2026Sale25,000US$22.37US$559K987KApr 1, 2026